<DOC>
	<DOC>NCT02344875</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetics, safety and pharmacodynamics after single oral administration of FYU-981 to male and female elder subjects in comparison with non-elder subjects.</brief_summary>
	<brief_title>Clinical Pharmacology of FYU-981 (Elder Subjects)</brief_title>
	<detailed_description />
	<criteria>Japanese adult subjects 2035 Years (nonelder groups) 65 Years (elder groups) Body mass index: &gt;=18.5 and &lt;25.0 Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>